P

ProKidney Corp
D

PROK

0.70100
USD
0.01
(0.75%)
مغلق
حجم التداول
30,250
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
90,804,821
الأخبار المقالات

العنوان: ProKidney Corp

القطاع: Healthcare
الصناعة: Biotechnology
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment.Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.